Corcept Therapeutics
CORT
CORT
228 hedge funds and large institutions have $1.84B invested in Corcept Therapeutics in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 72 increasing their positions, 83 reducing their positions, and 19 closing their positions.
Holders
228
Holders Change
+20
Holders Change %
+9.62%
% of All Funds
3.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
41
Increased
72
Reduced
83
Closed
19
Calls
$10.6M
Puts
$7.43M
Net Calls
+$3.22M
Net Calls Change
-$8.08M
Top Buyers
1 |
1
D.E. Shaw & Co
New York
|
$25.2M |
2 |
2
SG Americas Securities
New York
|
$16.1M |
3 |
GLA
3
Great Lakes Advisors
Chicago,
Illinois
|
$8.78M |
4 |
4
BlackRock
New York
|
$347M |
5 |
5
Voloridge Investment Management
Jupiter,
Florida
|
$8.7M |